Logo-ps
Pharm Sci. 2018;24(1): 31-37.
doi: 10.15171/PS.2018.06

Scopus ID: 85046094048
  Abstract View: 1017
  PDF Download: 676

Research Article

Probing Angiotensin Converting Enzyme (ACE) Domain-Dependent Inhibition of Onopordia, Isolated from Onopordon acanthium L., Using a Continuous Fluorescent Assay

Niusha Sharifi 1, Khosro Khajeh 2, Shabnam Mahernia 3, Saeed Balalaie 4, Ghasem Ataie 1, Raheleh Jahanbani 5, Massoud Amanlou 1,3* ORCID logo

1 Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
2 Faculty of Biological Sciences, Department of Biochemistry, Tarbiat Modares University, Tehran, Iran.
3 Department of Medicinal Chemistry, Faculty of Pharmacy, Drug Design & Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.
4 Peptide Chemistry Research Center, K. N. Toosi University of Technology, Tehran, Iran.
5 Institute of Biochemistry & Biophysics (IBB), University of Tehran, Tehran, Iran.

Abstract

Background: Somatic ACE is a two-domain protein, C and N which are resulted from gene duplication. Presence of two active sites with particular properties, demonstrates functional significance of each domain. Increased levels of circulating N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP), could be the result of ACE N-domain selective inhibition. Moreover, ACE C-domain specific inhibitors are able to inactivate bradykinin and inhibit the conversion of angiotensin I to angiotensin II in order to regulate blood pressure as well as reduced side effect profiles. Methods: The present study was designed to determine ACE domain specificity of the novel ACE inhibitor, onopordia which was recently isolated from Onopordon acanthium L. The ACE inhibition activity was determined using Abz-SDK (Dnp)P-OH and Abz-LFK(Dnp)-OH as ACE domain selective substrates. IC50 values of onopordia determined and compared with those of captopril as the standard. Results: IC50 values of onopordia for ACE N and C- domains were 180 µM and 244 µM respectively which demonstrated approximately similar affinity of the mentioned compound to ACE C and N-domains. A pharmacophore model was further generated based on onopordia interactions with the relevant ACE domain active sites. Conclusion: According to onopordia interactions in the ACE C and N-domain active sits, it is a potential to generate more potent and also specific inhibitor based on this new scaffold by doing accurate adjustments. Therefore, this study provides the molecular basis for further designing ACE inhibitors, which are new therapeutics in combating tissue fibrosis diseases.
Keywords: Angiotensin-I converting enzyme, ACE N-domain, ACE C-domain, Onopordon acanthium L., AcSDKP, Fibrosis
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 1017

Your browser does not support the canvas element.


PDF Download: 676

Your browser does not support the canvas element.

Submitted: 30 Aug 2017
Revision: 29 Nov 2017
Accepted: 02 Dec 2017
ePublished: 15 Mar 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)